OncoCyte Corp (OCX)
2.69
-0.09
(-3.22%)
USD |
NASDAQ |
May 03, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
OncoCyte Cash and Short Term Investments (Quarterly): 9.432M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.432M |
September 30, 2023 | 14.22M |
June 30, 2023 | 17.90M |
March 31, 2023 | 12.36M |
December 31, 2022 | 20.43M |
September 30, 2022 | 32.47M |
June 30, 2022 | 45.42M |
March 31, 2022 | 20.99M |
December 31, 2021 | 33.85M |
September 30, 2021 | 44.26M |
June 30, 2021 | 47.53M |
March 31, 2021 | 59.79M |
December 31, 2020 | 7.818M |
September 30, 2020 | 10.65M |
June 30, 2020 | 17.14M |
March 31, 2020 | 16.90M |
December 31, 2019 | 22.45M |
September 30, 2019 | 19.86M |
Date | Value |
---|---|
June 30, 2019 | 36.34M |
March 31, 2019 | 39.86M |
December 31, 2018 | 8.462M |
September 30, 2018 | 11.65M |
June 30, 2018 | 11.02M |
March 31, 2018 | 13.56M |
December 31, 2017 | 8.36M |
September 30, 2017 | 12.03M |
June 30, 2017 | 9.757M |
March 31, 2017 | 13.00M |
December 31, 2016 | 12.41M |
September 30, 2016 | 15.09M |
June 30, 2016 | 5.617M |
March 31, 2016 | 7.635M |
December 31, 2015 | 10.54M |
September 30, 2015 | 12.01M |
December 31, 2014 | 3.537M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
7.818M
Minimum
Dec 2020
59.79M
Maximum
Mar 2021
25.78M
Average
20.43M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Fonar Corp | 53.26M |
XWELL Inc | 23.05M |
ProPhase Labs Inc | 4.736M |
Applied DNA Sciences Inc | 3.359M |
Veracyte Inc | 216.45M |